Source:Clinical Immunology
Author(s): Ali Mirza, Yang Mao-Draayer
Individuals with Multiple Sclerosis (MS) have a distinct intestinal microbial community (microbiota) and increased low-grade translocation of bacteria from the intestines into the circulation. Immunopathologies shared with MS are regulated by bacteria reduced in individuals with MS. These bacteria regulate systemic and central nervous system (CNS) immunity including regulatory T cell function, blood-brain barrier (BBB) permeability, CNS-resident cells. This review discusses the MS intestinal microbiota structure implication on MS systemic- and CNS-immunopathology. We introduce the possible contributions of MS low-grade microbial translocation (LG-MT) to the development of MS, and end on a discussion on microbiota therapies for MS patients.
http://ift.tt/2nmidbb
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου